Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03876314 · ClinicalTrials.gov registry record · NA
Physical Activity, Alzheimer's Disease and Cognition Relative to APOE Genotype
A NA study, sponsored by University of North Carolina, Greensboro.
- Completed
- Registry status
- NA
- Development phase
- 180
- Enrollment target
NCT03876314 is a NA study that has completed, run by University of North Carolina, Greensboro. The registered enrollment target is 180 participants.
The verdict
NCT03876314, a NA study, has completed, sponsored by University of North Carolina, Greensboro.
- COMPLETED
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
Study Summary
Physical activity and Alzheimer's disease (PAAD-2) is a randomized control trial that will assess the effects of exercise on middle-aged (40-65 years) cognitively normal adults who have a heightened risk of Alzheimer's disease (AD) due to family history (FH+). The investigators will also assess the extent to which this effect is moderated by apolipoprotein epsilon-4 (APOE4) carrier status, and will gather critical new experimental evidence on the use of physical activity to improve cognitive performance by persons at the greatest risk of Alzheimer's disease.
Interventions
- BEHAVIORAL Physical Activity Condition
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2019-05-23 |
| Est. Completion | 2024-12-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03876314
The ClinicalTrials.gov registry entry for NCT03876314 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Greensboro, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Physical Activity Condition is the first listed.
NCT03876314 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03876314 about?
NCT03876314 is a clinical study titled "Physical Activity, Alzheimer's Disease and Cognition Relative to APOE Genotype". Physical activity and Alzheimer's disease (PAAD-2) is a randomized control trial that will assess the effects of exercise on middle-aged (40-65 years) cognitively normal adults who have a heightened risk of Alzheimer's disease (AD) due to family history (FH+). The investigators will also assess the ...
What is the current status of trial NCT03876314?
This trial is currently completed. It is a NA study. The enrollment target is 180 participants. The study started on 2019-05-23. Estimated completion is 2024-12-21.
What interventions are being tested in trial NCT03876314?
The interventions under investigation include: Physical Activity Condition (BEHAVIORAL).
Who is sponsoring clinical trial NCT03876314?
This trial is sponsored by University of North Carolina, Greensboro, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.